Jpmorgan Chase & CO Omega Therapeutics, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OMGA
# of Institutions
68Shares Held
45.4MCall Options Held
36.9KPut Options Held
33.5K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$30.4 Million7.23% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$3.65 Million3.95% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$1.93 Million0.01% of portfolio
-
Artal Group S.A. Luxembourg, N41.32MShares$1.38 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$1.16 Million0.0% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $49.8M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...